CRT 2026 Faculty Agreement to Participate

Faculty(s)

• 

  Michael G. Dwyer, PhD

  Associate Professor of Neurology and Biomedical Informatics
  University at Buffalo
  Buffalo, New York, United States

  Disclosure information not submitted.
• 

  Abdallah El Sabbagh, MD

  Interventional Cardiologist
  Mayo Clinic
  Jacksonville, Florida, United States

  Disclosure(s): No financial relationships to disclose
• 

  Stephen G. Ellis, MD, FACC, FSCAI

  Director of Interventional Cardiology, Senior Academic Officer
  Cleveland Clinic
  Beachwood, Ohio, United States

  Disclosure information not submitted.
• ME

  Marvin Eng, MD

  Structural Heart Disease Medical Director
  Banner University Medical Center
  Phoenix, Arizona, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Georges Ephrem, MD, MSc, FACP, FACC, FSCAI

  Assistant Professor
  UTHSC
  Memphis, Tennessee, United States

  Disclosure(s): Zoll Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Khady Fall, MD

  Director of Operation & Program Manager of Imaging /Physiology
  Columbia University Medical Center-NYP
  New York, New York, United States

  Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Conavi: Consulting Fees (e.g., advisory boards) (Ongoing); SpectraWAVE: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  William F. Fearon, MD

  Professor of Medicine Director, Interventional Cardiology
  Stanford University School of Medicine
  Stanford, California, United States

  Disclosure information not submitted.
• 

  Tim A. Fischell, MD, FACC, MSCAI

  Director of Cardiovascular Research
  Borgesd Heart Institute
  Kalamazoo, Michigan, United States

  Disclosure(s): Balosmark, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); VivaCath, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)
• 

  Peter J. Fitzgerald, MD, PhD

  Director, Center for CV Innovation
  Stanford University
  Stanford, California, United States

  Disclosure information not submitted.
• 

  Laura Flannery, MD

  Structural Interventional Cardiologist
  OhioHealth Riverside Methodist Hospital
  Upper Arlington, Ohio, United States

  Disclosure information not submitted.
• 

  Jason Foerst, MD

  Medical Director of Structural Heart Program
  Carilion Clinic
  Salem, Virginia, United States

  Disclosure information not submitted.
• 

  Gregory P. Fontana, MD

  Director, CardioVascular Institute
  HCA Healthcare
  Thousand oaks, United States

  Disclosure information not submitted.
• 

  Farshad Forouzandeh, MD, PhD

  Associate Professor of Medicine, Interventional Cardiologist
  Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH
  Cleveland, Ohio, United States

  Disclosure information not submitted.
• 

  Brian Forrestal, MD

  Interventional Cardiologist
  Morristown Medical Center
  Mountain Lakes, New Jersey, United States

  Disclosure information not submitted.
• 

  Hemal Gada, MD

  Structural Interventional Cardiologist
  UPMC Central PA

  Disclosure information not submitted.
• 

  Sameer A. Gafoor, MD

  Medical Director, Structural Heart Disease
  Swedish Heart and Vascular
  Seattle, Washington, United States

  Disclosure information not submitted.
• 

  Santiago Garcia, MD

  Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
  The Christ Hospital
  Cincinnati, Ohio, United States

  Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
• 

  Mario FL Gaudino, MD, PhD, MSCE

  Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery (II)
  Weill Cornell Medicine|NYPresbyterian
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Philippe Généreux, MD

  Director, Valve & Structural Heart Center
  Morristown Medical Center
  Morristown, New Jersey, United States

  Disclosure information not submitted.
• 

  Isaac George, MD

  Associate Professor of Surgery (in Medicine)
  New York Presbyterian - Columbia University Medical Center
  New York, New York, United States

  Disclosure(s): Atricure: Consulting Fees (e.g., advisory boards) (Ongoing); BCI: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); CardioMech: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); DurVena Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing); ZimmerBioMet: Consulting Fees (e.g., advisory boards) (Ongoing)
• JG

  Jon C. George, MD

  Director, Cardiac Cath Lab
  Einstein Medical Center
  Philadelphia, Pennsylvania, United States

  Disclosure information not submitted.
• 

  Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

  Interventional Cardiologist
  John Muir Health Cardiovascular Institute
  San Francisco, California, United States

  Disclosure(s): AtaCor: Stock Options [in privately held companies] (Ongoing)
• 

  C. Michael Gibson, MD

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Ian C. Gilchrist, Sr., MD, MSCAI

  Professor of Interventional Cardiology
  Dartmouth Hitchcock Medical Center
  Moultonborough, New Hampshire, United States

  Disclosure(s): No financial relationships to disclose
• 

  Gauravpal Singh Gill, MD

  Interventional Cardiologist
  James River Cardiology, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Donald D. Glower, MD

  Duke University Medical Center
  Durham, NC, United States

  Disclosure information not submitted.
• 

  Sachin S. Goel, MD, FACC, FSCAI

  Medical Director, Structural Heart Interventions
  Houston Methodist DeBakey Heart & Vascular Center
  Houston, Texas, United States

  Disclosure information not submitted.
• 

  Bill D. Gogas, MD, PhD

  Interventional Cardiologist
  The Spencer B. King III Cath Lab, Greece

  Disclosure information not submitted.
• 

  Steven L. Goldberg, MD, FSCAI, FACC

  Interventional Cardiologist
  Three Crosses Regional Medical Center, Las Cruces, New Mexico
  Monterey, California, United States

  Disclosure information not submitted.
• 

  Andrew M. Goldsweig, MD, MS

  Director, Cardiovascular Clinical Research
  Baystate Medical Center
  West Hartford, Connecticut, United States

  Disclosure information not submitted.
• 

  Juan F. Granada, MD

  Executive Director & Chief Innovation Officer
  CRF Skirball Center for Innovation
  Orangeburg, NY, United States

  Disclosure information not submitted.
• JG

  J. Aaron Grantham

  United States

  Disclosure information not submitted.
• 

  William A. Gray, MD, FSCAI

  System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
  Main Line Health
  Wynnewood, Pennsylvania, United States

  Disclosure information not submitted.
• 

  Jan Griffin, MD

  Associate Professor of Medicine
  Medical University of South Carolina
  Charleston, South Carolina, United States

  Disclosure information not submitted.
• 

  Jonathan Grinstein, MD

  Advanced Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation Physician
  University of Chicago
  MedStar Washington Hospital Center
  Bethesda, MD, United States

  Disclosure information not submitted.
• 

  Mayra E. Guerrero, MD, FACC, FSCAI

  Professor of Medicine
  Mayo Clinic Hospital
  Rochester, Minnesota, United States

  Disclosure information not submitted.
• 

  Maya Guglin, MD

  Director of Heart Failure/Transplant/MCS
  Indiana University
  Indianapolis, Indiana, United States

  Disclosure information not submitted.
• 

  Michael Guiry, PA-C, MBA

  Vice President Cardiovascular Service Line
  St. Luke's University Health Network
  Blairstown, New Jersey, United States

  Disclosure information not submitted.
• 

  Rajiv Gulati, MD, PhD

  Chair, Division of Interventional Cardiology
  Mayo Clinic
  Rochester, Minnesota, United States

  Disclosure information not submitted.
• 

  Luis Guzman, MD, FACC, MSCAI

  Medical Director, Cardiac Cath Lab
  Mary Washington Hospital
  Richmond, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Rebecca T. Hahn, MD

  Director of Interventional Echocardiography
  Columbia University/NewYork-Presbyterian Hospital
  New York, New York, United States

  Disclosure information not submitted.
• 

  Allison B. Hall, MD, FRCPC

  Interventional Cardiologist, Clinical Assistant Professor of Medicine
  NL Health Services/Memorial University of Newfoundland
  St. John's, Newfoundland and Labrador, Canada

  Disclosure information not submitted.
• 

  James E. Harvey, III, MD

  VP and CMO - Heart & Vascular Service Line
  WellSpan Health

  Disclosure information not submitted.
• 

  Tarek Helmy, MD, FACC, MSCAI

  Regional Chairman of the Cardiovascular Service Line
  Trinity Health of New England
  West Hartford, Connecticut, United States

  Disclosure information not submitted.
• 

  Cara Hendry, MD FRCP LLM PG Cert Clin Ed

  Consultant Cardiologist
  Manchester University NHS Foundation Trust
  Bolton , England, United Kingdom

  Disclosure information not submitted.
• 

  Timothy D. Henry, MD

  Director, The Carl and Edyth Lindner Center for Research and Education
  The Christ Hospital
  Bellevue, Kentucky, United States

  Disclosure information not submitted.